AXS gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.

GLDD, LTM and EWCZ made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 13, 2025.

BAC shares rise 18.2% in a month. Let's have a closer look at how the company will navigate the current ambiguities and performance over the rest of the year.

Investors need to pay close attention to USPH stock based on the movements in the options market lately.

XOMA Royalty (XOMA) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.26 per share. This compares to loss of $0.86 per share a year ago.

Mirion Technologies (MIR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

If you are looking for stocks that are well positioned to maintain their recent uptrend, NeuroPace (NPCE) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Allient (ALNT) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Greenland Technologies (GTEC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Great Lakes Dredge & Dock (GLDD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Inflation rates slowed to 2.3% in April, with cheaper oil and lower egg prices helping.

I first bought Meta shares in 2018 during the Cambridge Analytica sell-off and have seen a 270% appreciation since. One of the company's main competitive advantages lies in its daily engagement of 3.35 billion users, serving 49.34% of the global population outside China. Meta owns three of the four most popular social media platforms. AI will unlock productivity, and more time will be spent in the virtual world, including Meta's offerings.

The already turbulent situation for UnitedHealth (NYSE: UNH) has only worsened with a deluge of adverse developments. The latest turmoil on Tuesday, May 13 ensured that UNH stock collapsed 10.17% in pre-market from its latest closing price of $378.75 to $340.25 at the time of publication.

Denver, Colorado--(Newsfile Corp. - May 13, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, believes that Core Gaming's AI COMIC App, announced on May 6, 2025, rocketing to nearly 300,000 users and validating Core Gaming's vision as part of Siyata Mobile's (NASDAQ: SYTA) $160 million merger with Core Gaming, which includes a special mechanism on the merger closing date that's set to close in Q2 2025. As a publicly traded entity post-merger, combined with Siyata Mobile, Core Gaming can move forward as a Nasdaq listing.

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Dave Rosa – CEO Ron McClurg – CFO Chris Volker - COO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good day, ladies and gentlemen. Welcome to the Second Quarter of Fiscal Year 2025 Financial Results Conference Call for NeuroOne Medical Technologies Corporation.

EDIT announces encouraging first-quarter 2025 results, as both earnings and revenues beat estimates.

Nayax (NYAX) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.15 per share a year ago.

Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.29 per share a year ago.

MIAMI, May 13, 2025 – PRISM MediaWire – SKYX (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a highly disruptive advanced and smart home platform technology company for homes and buildings, with more than 97 issued and pending patents globally and a portfolio of over 60 lighting and home décor websites, announced today that it has secured approximately